Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

por Skljarevski, Vladimir, Frakes, Elijah P., Sagman, Doron, Lipsius, Sarah, Heinloth, Alexandra N., Dueñas Tentori, Héctor J.
Publicado 2012

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse e...

por Perahia, David G, Bangs, Mark E, Zhang, Qi, Cheng, Yingkai, Ahl, Jonna, Frakes, Elijah P, Adams, Michael J, Martinez, James M
Publicado 2013